SuperworthAnteris Technologies Global EPS AVR
Diluted earnings per share by quarter and over the last twelve months, from 2024.
- Last 12 months, to Jun 30, 2026
- −$1.94
- Latest quarter, Q2 FY26
- −$0.30
- Fiscal year 2025
- −$2.55
Anteris Technologies Global's earnings per share was −$1.94 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.30.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2.55 | n/a |
| FY2024 | −$3.78 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.30 | n/a | −$1.94 | |
| Q1 FY26 | −$0.28 | n/a | −$2.22 | |
| Q4 FY25 | −$0.74 | n/a | −$2.55 | |
| Q3 FY25 | −$0.62 | n/a | −$2.63 | |
| Q2 FY25 | −$0.58 | n/a | −$3.08 | |
| Q1 FY25 | −$0.61 | n/a | −$3.48 | |
| Q4 FY24 | −$0.82 | n/a | −$3.78 | |
| Q3 FY24 | −$1.07 | n/a | n/a | |
| Q2 FY24 | −$0.98 | n/a | n/a | |
| Q1 FY24 | −$0.91 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Anteris Technologies Global's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AVRAnteris Technologies Global | −$1.94 | |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MOVMovado | $1.80 | +137% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| INFUInfuSystem | $0.41 | +78% a year |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| Peer median | $0.94 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Anteris Technologies Global
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.